An interventional study of peer support in Chronic Kidney Disease Requiring Hemodialysis, sponsored by pınar dogan. Completed at 1 site in Turkey (Türkiye). Per ClinicalTrials.gov, last updated 2025-08-20.
Sponsored by pınar dogan · Not applicable, Interventional, and Supportive care
This study was designed as an interventional, pretest-posttest controlled trial to examine the effects of peer interaction on disease adaptation and self-care ability in patients newly diagnosed with chronic kidney failure and starting dialysis. The main hypothesis:
H1: Structured peer support provided to patients receiving hemodialysis treatment has a positive effect on their level of adaptation to the disease.
H2: Structured peer support provided to patients receiving hemodialysis treatment has a positive effect on their self-care power.
Researchers will compare control group to see if adaptation to the dieases and self-care power.
Patients in the intervention group received peer support during their hospital stay, while those in the control group followed the routine clinical process.
This study was conducted with 64 patients in the nephrology clinic of a Training and Research Hospital in Istanbul. Data were collected using the Personal Information Form, the Chronic Illness Adaptation Scale, and the Self-Management of Chronic Illness Scale. Patients in the intervention group received peer support during their hospital stay, while those in the control group followed the routine clinical process. Participants in the intervention group took part in a structured peer support program, with pre-test data collected through the Self-Care Management Scale in Chronic Illness and the Chronic Illness Adaptation Scale. The program consisted of 4-6 sessions over one week, each lasting 30-45 minutes, focusing on disease information, self-care behaviors, psychosocial coping, and motivation, delivered by trained peers of similar age and gender. Post-test data were collected after the program to assess changes and analyze the effect of structured peer support.
3,144 studies on the registry are indexed under Renal Insufficiency, Chronic; 704 are open to participants now.
This study's enrollment of 64 is below the median of 74 across 2,176 interventional studies indexed under Renal Insufficiency, Chronic.
Browse Renal Insufficiency, Chronic studies →This is the only study on the registry with pınar dogan as lead sponsor.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
In this group, structured peer support was provided for 1 week in addition to routine care practices applied in the clinic.
Behavioral: peer support
group monitored with routine clinical care
This intervention is a one-week, structured peer support program for patients in the first six months of hemodialysis treatment.
Chronic disease adaptation scale
It was used to determine the level of adaptation of hemodialysis patients to the disease. The minimum possible score on the scale is 25, and the maximum is 125. Higher scores on the scale indicate an increased level of adaptation to the illness.
Time frame: Day 1, upon hospital admission) and at discharge (average of 7 days after admission.
Self-care management scale
It was used to measure patients' ability to manage their self-care. The possible score on the scale ranges from 35 to 175, and higher scores indicate better self-care management.
Time frame: Day 1, upon hospital admission) and at discharge (average of 7 days after admission.
Plan to share: Yes — Study protokol may be share for 1 year
Supporting information: Study protocol
No publications or documents are linked to this record.
This study is completed, as verified in Aug 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.